CUSIP 20678X106COMQ1 2025
16 filings · latest Apr 10, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ifp Advisors, Inc | 20.0K | $904 |
| 4 | Nov 6, 2024 | St George Street Capital | 13G/A | — | — | SEC |
| 5 | Oct 18, 2024 | Nirland Ltd | 13G/A | 2.0% | 2.00M | SEC |
| 6 | Oct 11, 2024 | Astrazeneca PLC | 13G | 9.9% | 9.50M | SEC |
| 7 | Oct 7, 2024 | Nirland Ltd | 13G/A | 8.3% | 8.09M | SEC |
| 8 | Sep 19, 2024 | Corvus Capital Ltd. | 13D/A | 31.3% | 30.05M | SEC |
| 9 | Aug 13, 2024 | Nirland Ltd | 13G/A | 14.8% | 14.50M | SEC |
| 10 | Feb 12, 2024 | Polar Asset Management Partners Inc. | 13G/A | 1.3% | 950.0K | SEC |
See the full Schedule 13D/13G history for Conduit Pharmaceuticals Inc.
Unlock full history